Uni-Bio Science Group Limited
UNBSF
$0.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 75.69M | 73.31M | 70.87M | 67.93M | 65.02M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 75.69M | 73.31M | 70.87M | 67.93M | 65.02M |
| Cost of Revenue | 13.48M | 12.64M | 11.78M | 11.25M | 10.72M |
| Gross Profit | 62.21M | 60.68M | 59.09M | 56.68M | 54.30M |
| SG&A Expenses | 42.82M | 41.45M | 40.05M | 37.90M | 35.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -449.30K | -579.30K | -709.10K | -911.80K | -1.11M |
| Total Operating Expenses | 61.63M | 59.75M | 57.82M | 54.44M | 51.10M |
| Operating Income | 14.06M | 13.56M | 13.05M | 13.48M | 13.92M |
| Income Before Tax | 12.61M | 12.15M | 11.67M | 12.49M | 13.31M |
| Income Tax Expenses | 889.60K | 983.10K | 1.08M | 869.50K | 663.80K |
| Earnings from Continuing Operations | 11.72 | 11.17 | 10.59 | 11.62 | 12.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.72M | 11.17M | 10.59M | 11.62M | 12.64M |
| EBIT | 14.06M | 13.56M | 13.05M | 13.48M | 13.92M |
| EBITDA | 15.79M | 15.22M | 14.64M | 15.23M | 15.81M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 24.18B | 24.37B | 24.56B | 24.81B | 25.06B |
| Average Diluted Shares Outstanding | 24.18B | 24.37B | 24.56B | 24.81B | 25.06B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |